Schedule 13D ownership disclosure

HedgePath Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 42278K102

Event date: 2014-06-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
44.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001571049-14-002888
Form type
SC 13D
Filer
Inhibitor Therapeutics, Inc.
CIK
CIK 1042418
Filed
Jul 07, 2014
Reporting period
Jun 24, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub